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Abstract
Background: Antibiotics are the most common medicines prescribed to children in hospitals and the community,
with a high proportion of potentially inappropriate use. Antibiotic misuse increases the risk of toxicity, raises
healthcare costs, and selection of resistance. The primary aim of this systematic review is to summarize the current
state of evidence of the implementation and outcomes of pediatric antimicrobial stewardship programs (ASPs)
globally.
Methods: MEDLINE, Embase and Cochrane Library databases were systematically searched to identify studies
reporting on ASP in children aged 0–18 years and conducted in outpatient or in-hospital settings. Three
investigators independently reviewed identified articles for inclusion and extracted relevant data.
Results: Of the 41,916 studies screened, 113 were eligible for inclusion in this study. Most of the studies originated in
the USA (52.2%), while a minority were conducted in Europe (24.7%) or Asia (17.7%). Seventy-four (65.5%) studies used
a before-and-after design, and sixteen (14.1%) were randomized trials. The majority (81.4%) described in-hospital ASPs
with half of interventions in mixed pediatric wards and ten (8.8%) in emergency departments. Only sixteen (14.1%)
studies focused on the costs of ASPs. Almost all the studies (79.6%) showed a significant reduction in inappropriate
prescriptions. Compliance after ASP implementation increased. Sixteen of the included studies quantified cost savings
related to the intervention with most of the decreases due to lower rates of drug administration. Seven studies
showed an increased susceptibility of the bacteria analysed with a decrease in extended spectrum beta-lactamase
producers E. coli and K. pneumoniae; a reduction in the rate of P. aeruginosa carbapenem resistance subsequent to an
observed reduction in the rate of antimicrobial days of therapy; and, in two studies set in outpatient setting, an
increase in erythromycin-sensitive S. pyogenes following a reduction in the use of macrolides.
Conclusions: Pediatric ASPs have a significant impact on the reduction of targeted and empiric antibiotic use,
healthcare costs, and antimicrobial resistance in both inpatient and outpatient settings. Pediatric ASPs are now widely
implemented in the USA, but considerable further adaptation is required to facilitate their uptake in Europe, Asia, Latin
America and Africa.
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Background
Antimicrobials are the most commonly prescribed medi-
cine in pediatrics [1–3], with some estimates showing that
between 37 and 61% of hospitalized infants and children re-
ceive antibiotics [4–8]. It has been demonstrated that be-
tween 20 to 50% of these prescriptions are potentially
unnecessary or inappropriate [9–13], and that many chil-
dren still receive broad-spectrum antibiotics for viral infec-
tions or antibiotic courses that are significantly longer than
needed [14–18].
This unnecessary exposure increases the risk of ser-
ious side effects, raises healthcare costs, and contributes
significantly to the global emergency of antimicrobial
resistance [7, 19].
Although antimicrobial resistance occurs naturally and
can be acquired through gene transfer, antimicrobial mis-
use promotes the selection of resistant organisms [20, 21].
The emergence of resistant pathogens and their global
spread has rapidly become a major threat to public health
around the world, constituting a substantial burden for
patients, prolonging hospital stays, and leading to in-
creases in both healthcare costs and mortality [22–27].
This is particularly urgent due to the steady reduction in
the number of new antibiotic drugs approved over the last
few decades, particularly for children [28, 29].
The World Health Organization and the United Nations
at the General Assembly of 2016 identified the develop-
ment of country-level and institutional antimicrobial stew-
ardship programs (ASPs) as key instruments to tackle this
concern [30, 31].The concept of an ASP was formally in-
troduced in 2007 by the Infectious Disease Society of
America (IDSA) and defined as a set of coordinated inter-
ventions designed to improve antimicrobial use in terms
of selecting the appropriate agent, dose, route of adminis-
tration, and therapy duration without compromising pa-
tient outcomes [32]. The Pediatric Infectious Diseases
Committee on Antimicrobial Stewardship has defined the
development of ASPs in three different settings: inpatients,
special populations (e.g. oncology), and outpatients. In-
deed, the characteristics of specific ASPs may vary to best
fit the needs of different settings [33]. The primary aim of
this review is to summarize the current state of evidence
on how ASPs are conducted in pediatrics inpatients and
outpatients globally, informing practice in the field.
Materials and methods
Study design and search strategy
A review was conducted according to the Preferred
Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) guidelines [34]. Working with a
medical librarian, we conducted a systematic search of
the MEDLINE, Embase, and Cochrane Library databases,
including citations from January 1, 2007, to November
21, 2018, with a strategy combining Medical Subject
Heading (MeSH) and free-text terms for ‘children’ AND
‘antimicrobial’ AND ‘stewardship.’ The full strategy is
provided in the Additional file 1.
Inclusion criteria
Studies were eligible for full-text review if they included
both patients younger than 18 years and were conducted
in outpatient or in-hospital settings. Randomized con-
trolled trials, controlled and non-controlled before-and-
after studies, controlled and non-controlled interrupted
time series, and cohort studies were included.
Exclusion criteria
Review articles, case series, letters, notes, conference ab-
stracts, and opinion articles were excluded. Papers on both
adults and children where extraction of pediatric data was
not possible were also excluded. We excluded studies pub-
lished before 2007, as the concept of antimicrobial steward-
ship was formally introduced that year. We did not include
articles about malaria, HIV, viral and fungal treatments.
Study selection
Assessments of the titles, abstracts, and full texts were
conducted independently by two investigators (EB and
MD). Any disagreement regarding study selection was
resolved by discussion with a third reviewer (DD). The
selection process is summarized in Fig. 1.
Data collection
Data were extracted using a standardized data collection
form which summarized information about authors, year of
publication, study design, country, study period, setting, mul-
ticentric involvement, type of intervention, and main results.
Results
Of 41,916 titles and abstracts, 113 were eligible for inclu-
sion in this review. Most of the studies (98/113, 86.7%)
originated from high-income countries (defined according
to the World Bank list of economies in September 2018)
[35] and a slight majority described ASPs implemented in
the USA (59/113, 52.2%). Only 28/113 (24.7%) papers de-
scribe the implementation of an ASP in Europe (Ireland,
Cyprus, Czech Republic, Germany, Greece, Spain, France,
Netherlands, Switzerland, UK, and Italy); 20/113 (17.7%)
describe the implementation of an ASP in Asia (India,
Indonesia, Israel, Philippines, Russia, Saudi Arabia,
Singapore, South Korea, Pakistan, Bangladesh, Japan, and
China), with the remainder describing ASPs implemented
in Benin, Argentina, and Canada.
Fifty studies were published between 2016 and 2018 [50/
113, 44.5% in total; 28/50 (56%) from USA, 11/50 (22%)
from Asia, and 11/50 (22%) from Europe], three times more
than during the 2007–2009 period [16/113, 14.2% in total;
6/16 (37.5%) from the USA, 5/16 (31.3%) from Asia, 4/16
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(25%) from Europe, 1/16 (6.3%) from Africa]. Geographical
distribution of articles is shown in Fig. 2.
Author, publication year, study design, country, study
period, setting, type of intervention, and main results are
summarized in Table S1 (please see Additional file 2).
Thirty-nine (39/113, 34.5%) were multicentre studies:
43.6% (17/39) were set in the USA, 35.9% (14/39) in
Europe, and the rest 20.5% in Asia and Africa (8/39).
ASPs setting and type of intervention
Ninety-two studies [92/113, 81.4% in total; 50/92
(54.3%) from the USA and 21/92 (22.8%) from Europe]
described ASP implementation in the hospital setting
[36–120]. Most of the ASP interventions in this setting
were audit and feedback [53, 55–58, 62, 67–71, 74, 76,
78, 79, 82–84, 86, 89, 91, 92, 94, 107, 110, 111, 113,
120–123] guidelines implementation [36, 37, 40, 42, 43,
54, 59, 60, 73, 80, 83–85, 87, 90, 91, 99, 100, 104, 106,
109, 115, 119, 121, 122, 124, 125], and more specific ap-
proaches based on laboratory testing and check-lists [38,
42, 51, 52, 54, 61, 65, 75, 77, 81, 87, 91, 95, 96, 98, 99,
101–103, 111, 112, 114, 116–119, 124–131]. Eight inter-
ventions conducted in the hospital setting monitored
perioperative prophylaxis [3/8 (37.5%) in the USA, 3/8
(37.5%) in Europe the rest in Argentina and Canada (2/
8, 25%)]) [51, 54, 59, 69, 87, 91, 98] including one imple-
mented in the NICU ward [115].
Twenty-one papers [21/113, 18.6% in total; 9/21
(42.8%) from USA, 7/21 (33.3%) from Europe, 4/21
(19%) from Asia, and 1/21 (4.7%) from Africa] described
ASP in an outpatient setting [126–130, 132–147], among
which seven were focused on education combined with
audit and feedback [129, 132, 134, 138, 141, 142, 145–
147]. ASP interventions stratified for different settings
are summarized in Table 1.
ASPs outcomes
Ninety (90/113, 79.6%) studies reported as their main
outcome changes in antimicrobial prescribing with a re-
duction in inappropriate prescriptions [45/90 (50%) from
the USA, 23/90 (25.5%) from Europe, and 24.5% from
Asia) [36–39, 41, 43–50, 52–62, 64–84, 86, 87, 89–92,
Fig. 1 Flowchart of the study selection process
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94–107, 110–114, 116–121, 123–135, 137, 138, 141–
143, 147, 148]; sixty-one of these were studies with a sin-
gle intervention, mainly with an audit and feedback
strategy (19/61, 31.1%) [53, 56–58, 62, 64, 67–71, 74, 76,
82–86, 89, 91, 92, 94, 107, 110, 111, 113, 120, 121, 123,
127, 132, 134, 135, 138, 141, 142, 147]. Eighteen papers
(18/113, 15.9%) [40–42, 51, 54, 60, 71, 85, 87, 91, 98,
105, 106, 125, 135, 136, 138, 142] showed an increase in
compliance among prescribing physicians; half of the pa-
pers analysing this outcome were from USA and Canada
(10/18, 55.5%), and the main ASPs adopted were guide-
lines (9/34, 26.5%) [40, 42, 54, 60, 85, 87, 91, 106, 125,
142], doctors education (5/34, 14.7%) [54, 91, 98, 138,
142] and other not common ASPs such as antibiotic
order set [42, 51], and checklists [87, 91]. Sixteen of the
included studies [16/113, 14.2% in total; 7/16 (43.7%)
from USA, 6/16 (37.5%) from Asia and the rest (18.7%)
from Europe] quantified cost savings related to the inter-
vention [39, 49, 52, 64, 66, 69, 73, 86, 89, 92, 97, 101,
102, 122–124]. Decreases in costs were most often due
to lower rates of drug administration. Twelve papers
[12/113, 10.6% in total; 6/12 (50%) from Asia and the
rest equally from Europe and USA] took into consider-
ation changes in antimicrobial resistance [52, 58, 66, 67,
72, 106, 112, 115, 124, 137, 141] as an outcome used
mostly to analyse audit and feedback ASP [58, 67, 74,
141]. In five cases, no changes were reported [58, 66, 74,
106, 115], while the other seven studies showed an in-
creased susceptibility of the bacteria analysed [52, 67, 72,
112, 124, 137, 141]. The most interesting results were a
decrease in extended spectrum beta-lactamase (ESBL)
producers E. coli and K. pneumoniae [72, 112, 124]; a re-
duction in the rate of P. aeruginosa carbapenem resist-
ance subsequent to an observed reduction in the rate of
antimicrobial days of therapy (DOT) [67, 124]; and, in
two studies set in outpatient setting, an increase in
erythromycin-sensitive S. pyogenes following a reduction
in the use of macrolides [137, 141]. See Table S1




Since 2007, ASPs have been proven to reduce inappro-
priate antimicrobial use and resistance, enhance patient
safety, and lower drug costs both in adult and pediatric
populations. More than 300 studies performed in the
adult setting have now been published [149–152], while
113 studies over the last twelve years were performed in
pediatric settings.
We conducted this scoping systematic review [153] to
provide an easily consultation compendium (divided by
country, study period, type of intervention and main
outcomes analysed) describing the state of art of ASPs
worldwide and to help clinicals to choose wisely which
program would fit better in their setting. This is the first
systematic scoping review analysing the implementation
of ASPs in pediatrics globally, in both inpatient and out-
patients settings. Previously, two systematic reviews had
been conducted which did not include ASPs interven-
tion in outpatient settings, with Smith et al. [154] limited
to inpatient interventions in the USA and Da Silva et al.
[155] limited to general pediatric wards and PICU.
It is interesting to notice that the relative number of
articles on pediatric ASPs published in Europe and Asia
increased between 2016 and 2018, compared to USA
where the spike was already observed in 2013–2015.
Moreover, there seems to be an ASPs research gaps in
certain area of the world, mostly in middle-low or low
income countries, that could be due to the fact that
Fig. 2 Area cartogram of the world with each country rescaled in proportion to number of study included in this review (R version 3.5.3)
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Table 1 Antimicrobial stewardship programs strategies and settings (2007–2018)
Audit and
feedback
Guidelines Physician Education Pre-Authorization Parents Education CDS tool CP Other
ED (15) 5 4 3 3




USA 3 1 1 2
Spain 1
ED + Pediatric ward (4) 1 3
Italy 1 1
USA 2
Hospital (all wards) (62) 23 11 4 10 14
Bangladesh 1
Canada 2 1 1
China 1 1 1
Germany 2
Greece 1





USA 17 6 1 5 9




Hospital (all wards), PICU excluded (3) 1 1 1
Argentina 1 1 1
Hospital (one ward) (3) 1 1 1
Bangladesh 1 1 1
Hospital (two wards) (1) 1
Russia 1
NICU (18) 4 3 2 2 7
France 1
India 1
Ireland 1 1 1
Netherlands 1
Philippines 1
USA 2 2 1 2 4
NICU + Hospital nursery (1) 1
Netherlands 1
NICU + PICU (2) 2
Switzerland 1
UK 1
Oncology ward (3) 1 1 1
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most ASPs program are under development and/or con-
sidered as part of new standard of care strategies. An
earlier review by Schweitzer et al. [156] found that the
overall quality of ASPs studies is low and has not
improved over time. Our research confirmed these pre-
vious finding with most of the studies having a before-
and-after design, most likely because of the low cost,
convenience, and simplicity of these designs.
ASPs are mainly based on two core strategies: pro-
spective audit and feedback, which involves inter-
action and feedback between an infectious disease
physician and the prescriber; and formulary restriction
and preauthorization requirements for specific agents
[32]. Implementation of both core strategies together
is strongly recommended by the ASP guidelines, but
we found just four studies (3.5%) where both ASPs
were implemented. These ASPs were implemented
more in the USA, with just seven core interventions
implemented in Europe. More accuracy in dosage and
better adherence to guidelines were obtained in these
studies worldwide, together with an overall decrease
in length of therapy and DOT, especially for cephalo-
sporins and fluoroquinolones.
According to the IDSA guidelines, ASPs should improve
antimicrobial use, leading to reductions in antimicrobial
resistance, adverse drug events, healthcare costs, and rates
of C. difficile infections. The most commonly reported
outcome in this review was a change in the prescribing of
antimicrobials, with less emphasis on healthcare costs,
safety, and resistance. Almost all the studies we reviewed
evaluating antimicrobial consumption showed a signifi-
cant reduction in inappropriate prescriptions [36–39, 41,
43–50, 52–62, 64–84, 86, 87, 89–92, 94–107, 110–114,
116–121, 123–135, 137, 138, 141–143, 147, 148]. Compli-
ance after ASP implementation reported in eighteen pa-
pers (15.9%) was high [40–42, 51, 54, 60, 71, 85, 87, 91,
98, 105, 106, 125, 135, 136, 138, 142], showing that ASP
interventions were generally well tolerated despite
Table 1 Antimicrobial stewardship programs strategies and settings (2007–2018) (Continued)
Audit and
feedback
Guidelines Physician Education Pre-Authorization Parents Education CDS tool CP Other
UK 1 1
USA 1
Outpatient (43) 10 6 9 5 4 9
Argentina 1
Bangladesh 1
Benin 1 1 1
Cyprus 1 1
Czech Republic 1 1
Israel 1 1 1
Italy 1 2 2
Saudi Arabia 1 1
Switzerland 1
UK 1 1
USA 4 1 3 3 4 3
Spain 1 1 1
Outpatient + ED (1) 1
Italy 1
Outpatient + Hospital (8) 2 2 2 2
China 2 2 2 2
PICU (5) 1 1 1 2
China 1 1 1
Pakistan 1
UK 1
PICU + Pediatric wards (2) 1 1
Indonesia 1 1
Grand Total 41 32 26 11 7 6 7 42
Entries in boldface represent total sum of ASP strategies according to setting (eg. ED/Guidelines = 5 it is the sum of France (1), Netherlands (1) and USA (3))
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theoretical concerns about prescriber opposition [82]. It is
critical that implementation of these tools be supported
by evaluation of compliance, because if the tools are too
complicated to use or too time-consuming, physicians will
not use them and the likelihood of inappropriate therapy
will increase. Papers analysing costs variations mostly in-
cluded just drug costs, even thought the cost savings of
ASPs should also include the reduction due to the shift
from intravenous to oral administration, the reduction in
length of hospital stays, and reduced rates of infections
due to multidrug-resistant bacteria [157]. Only three
European studies analysing healthcare costs were pub-
lished; the other studies were mostly from the USA or
other countries, such as China, that do not have universal
healthcare coverage. For this reason, formal economic
studies are also needed in pediatrics to show how ASP im-
plementation impacts all costs, not just the costs of anti-
microbials. Moreover, as Tacconelli et al. strongly advise
[158], microbiological analysis of common bacteria such
as S. aureus and K. pneumoniae before and after ASP
implementation should be included (just the 11.2% of the
papers considered reported microbiological data), as their
prevention and control are important potential indicators
of program success.
Overall, there was a paucity of literature on other,
more specific settings and interventions, resulting in
limited conclusions. Just 5.6% of studies were focused
on perioperative prophylaxis, 16.8% on EDs, 37.4% on
outpatient settings, and 6.5% on parental education
activities. It is notable that results from the Weddle
et al. study based on education intervention for pre-
scribers in the ED [145] showing a 2% decrease in
inappropriate antimicrobial prescribing were consist-
ent with results from a study in the USA based on an
adult population, which showed increased consistency
of therapy choice from 44.8 to 83% [159]. ASPs im-
plemented in outpatient settings, mainly involving
audit and feedback and education, also seemed effect-
ive in reducing antimicrobial prescriptions.
The primary limitation of our study is that only
three databases were searched, and not all pediatric
stewardship studies may have been identified. In
addition, available search indices and methods were
limited, as unpublished, unreported data and case re-
ports were not included. On the other hand, docu-
ment such as non peer-reviewed manuscript or report
are not assessed for accuracy or validity of the re-
search methodology leaving uncertainties about their
quality. Finally, no MeSH term was provided for anti-
microbial stewardship, a wide search-term strategy
was used to ensure the retrieval of all studies with an
intervention on antimicrobial use, even if the inter-
vention was not explicitly defined as antimicrobial
stewardship.
Future research – conclusion
Pediatric ASPs have a significant impact on antimicro-
bial use, healthcare costs, and antimicrobial resistance in
both inpatient and outpatient settings. Because of this
significant impact, pediatric ASPs are spreading rapidly
in the USA. Their implementation in Europe is still lim-
ited, possibly due to the fact that guidelines published so
far (IDSA/SHEA) are designed for the USA healthcare
system and easily adopted in this setting, while the diver-
sity of healthcare systems throughout Europe and Asia
implies a wide range of approaches to the same problem.
Secondly, across Europe we found a high variability of
funding opportunities and availability of specialists with
advance training in pediatrics, resources more consist-
ently and easily accessible in the USA.
Further efforts in developing pediatric ASPs are
urgently needed, particularly in order to improve the
collection of surveillance data regarding antimicrobials
use and antimicrobial resistance in pediatric populations.
More coordination, harmonization, and sharing of infor-
mation will lead to a more precise effects on healthcare
systems, and, as a result, on patient health as well. This
is especially important for pediatric patients, as lack of
data represents a greater challenge for pediatricians in
their daily practice compared with physicians treating
adult patients.
Supplementary information
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1186/s13756-019-0659-3.
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